Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial

AIM: To evaluate the prognostic value of tumor markers in a European cohort of patients with resectable gastric cancer. METHODS: We performed a post hoc analysis of the CRITICS trial, in which 788 patients received perioperative therapy. Association between survival and pretreatment CEA, CA 19-9, al...

Descripción completa

Detalles Bibliográficos
Autores principales: Slagter, Astrid E., Vollebergh, Marieke A., Caspers, Irene A., van Sandick, Johanna W., Sikorska, Karolina, Lind, Pehr, Nordsmark, Marianne, Putter, Hein, Braak, Jeffrey P. B. M., Meershoek-Klein Kranenbarg, Elma, van de Velde, Cornelis J. H., Jansen, Edwin P. M., Cats, Annemieke, van Laarhoven, Hanneke W. M., van Grieken, Nicole C. T., Verheij, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882113/
https://www.ncbi.nlm.nih.gov/pubmed/34714423
http://dx.doi.org/10.1007/s10120-021-01258-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882113/
https://www.ncbi.nlm.nih.gov/pubmed/34714423
http://dx.doi.org/10.1007/s10120-021-01258-6

Ejemplares similares